Adaptogens Beyond Stress: Energy, Sleep, and Cognition

The word “adaptogen” has become shorthand for “stress supplement.” That framing is narrow, and it undersells what this class of botanicals and fungi actually does.

Some of the most interesting recent research on adaptogens goes beyond cortisol, studying mitochondrial energy, nerve growth, secondary memory, sleep architecture, and hormonal axis regulation. 

The supplement category most associated with stress relief may turn out to be most useful for everything that stress depletes.

What Makes Something an Adaptogen

An adaptogen produces a non-specific physiological response: it doesn’t push the body in one direction, but helps it maintain equilibrium under different kinds of strain. 

The original definition, developed by Soviet pharmacologists in the 1940s, required three criteria: low toxicity at normal doses, a normalizing effect regardless of the direction of imbalance, and non-specific resistance to multiple stressor types. 

That last criterion is what makes adaptogens mechanistically interesting. They act on multiple systems, most consistently the HPA axis, and depending on the compound, mitochondrial and immune pathways.

Here are 6 showing up in recent research, and what it actually supports.

Rhodiola Rosea: Fatigue and Focus

Mechanism: Rhodiola's active compounds, rosavins and salidroside, appear to inhibit monoamine oxidase, reduce cortisol during acute stress, and support mitochondrial energy metabolism. Rhodiola has some of the most robust human evidence of any adaptogen outside ashwagandha.

The clearest signal is anti-fatigue. A 2024 narrative review by Lucius in Integrative and Complementary Therapies found modest benefit across exercise performance, mood, and fatigue states, with dosing and standardization shaping outcomes considerably. The cognition picture is more mixed: a 2026 systematic review by Scholey et al. in Journal of Cognitive Enhancement concluded rhodiola’s ergogenic effects are minor and outcome-dependent, helping fatigue-related cognitive decline more than sharpening cognition in rested, healthy people.

One caution: a randomized controlled trial by Punja et al. in PLOS ONE found that among nursing students on shift work, 42 days of rhodiola worsened fatigue scores relative to placebo on two validated scales. Population context matters here; acute academic stress may respond differently than chronic, sleep-disrupted occupational fatigue.

Dose & Who It’s For: 200 to 600 mg/day of standardized extract, typically taken in the morning given its mild stimulating effect. It may be most relevant for people under chronic occupational load rather than acute stress.

Lion’s Mane: Neuroplasticity 

Mechanism: Erinacines (from the mycelium) and hericenones (from the fruiting body) both act on nerve growth factor, the protein that stimulates neuron growth and maintenance. Erinacines appear to be the primary driver of central NGF stimulation, since hericenones may not reliably cross the blood-brain barrier. Lion’s mane (Hericium erinaceus) is the most mechanistically distinctive adaptogen here.

A 2025 systematic review in Frontiers in Nutrition reported that both compounds promote NGF and BDNF synthesis, essential for neural growth and synaptic plasticity. The most notable human data comes from a double-blind, placebo-controlled trial by Docherty et al. in Nutrients (2023): a single 1.8 g dose produced faster Stroop task performance at 60 minutes in 41 healthy adults, with a trend toward reduced subjective stress after 28 days. Acute effects from a single dose are unusual; most adaptogens take weeks to show measurable change.

Sourcing matters: most lion’s mane products use mycelium grown on grain substrates. Erinacines are present in mycelium but need substantial extraction to reach meaningful amounts; hericenones come from the fruiting body. Check extraction method before assuming equivalence.

Dose & Who It’s For: Single doses around 1.8 g show acute effects; the 28-day trial data suggests measurable benefit within a month of continued use. Most relevant for people prioritizing long-term neuroplasticity support.

Panax Ginseng: Memory

Mechanism: Ginsenosides, a class of triterpene saponins, are thought to influence several pathways relevant to cognition, including neurotransmitter signaling, neuroinflammation, synaptic plasticity, and cholinergic function. However, individual ginsenosides differ substantially in bioavailability, and the mechanisms responsible for cognitive effects in humans remain incompletely established. Ginseng also has a long history of traditional use and has been studied in a relatively large number of cognitive trials, although results have been inconsistent.

A 2026 systematic review by Scholey et al. in the Journal of Cognitive Enhancement found that the most consistent cognitive effects of Panax ginseng were on memory, with particularly robust acute findings following a single 400 mg dose of the standardized G115 extract. However, effects on attention were inconsistent: some doses improved attentional performance, while 200 mg or 600 mg produced slower performance on certain attention tasks in some studies, suggesting that cognitive effects may vary by dose and outcome measured.

A 2024 meta-analysis by Zeng et al. in Phytotherapy Research found a statistically significant but small improvement in memory across randomized trials, while effects on overall cognition, attention, and executive function were not significant. Differences in ginseng species, extract composition, dose, and ginsenoside profile complicate comparisons and standardization across products.

Dose & Who It’s For: Clinical cognitive studies have commonly used approximately 200–400 mg of standardized ginseng extract, with a single 400 mg dose of G115 producing some of the strongest acute memory findings. The evidence is most relevant to healthy adults interested in possible short-term memory support; evidence for sustained attention or broader cognitive enhancement is less consistent.

Reishi: Sleep 

Mechanism: Reishi’s bioactive triterpenes reduce pro-inflammatory markers including TNF-alpha, IL-1beta, and IL-6, but its sleep-specific pathway runs through GABAergic neurotransmission, the brain’s primary inhibitory signal that allows sleep onset. Reishi (Ganoderma lucidum) is the only adaptogen here with a primary signal pointing directly at sleep quality.

An 8-week trial presented at SLEEP 2026 reported 980 mg reishi extract reduced Insomnia Severity Index scores more than melatonin in adults with chronic insomnia, though that finding is a conference presentation, not yet peer-reviewed, and needs replication.

Dose & Who It’s For: Trials use continuous supplementation of 980 mg over eight or more weeks; give it weeks, not days. Most useful for people with existing sleep difficulty rather than healthy sleepers optimizing already-adequate rest.

Holy Basil: Cortisol Support

Mechanism: The active compounds, eugenol, rosmarinic acid, and ursolic acid, appear to modulate cortisol synthesis and breakdown while supporting antioxidant and anti-inflammatory pathways. Holy basil (Ocimum tenuiflorum, tulsi) has a more precise stress mechanism than most adaptogens.

A 2022 trial by Lopresti et al. in Frontiers in Nutrition enrolled 100 stressed adults through eight weeks of 250 mg/day of standardized extract or placebo, then ran an acute stress test at the end. Holy basil was associated with significantly lower salivary cortisol, salivary amylase, blood pressure, and subjective stress ratings after the stressor, plus improved subjective sleep quality. Because cortisol was measured under challenge rather than at rest, the supplement appears to blunt the physiological stress response itself.

The same trial found holy basil reduced hair cortisol, a three-month biological average of cortisol exposure, over 8 weeks, a more meaningful measure of chronic stress burden than a single blood draw.

Dose & Who It’s For: 250 mg/day of standardized extract, the dose used in the Lopresti trial, is a reasonable starting point. Most relevant for people whose stress shows up physiologically: elevated resting heart rate, disrupted sleep, heightened reactivity.

Shatavari: Perimenopause and Women’s Health

Mechanism: Saponins appear to interact with estrogen receptors, providing mild estrogenic activity that may buffer symptoms of declining endogenous estrogen. The effect is modest relative to hormone replacement therapy, with a different safety and tolerability profile. 

Shatavari (Asparagus racemosus) is the most specifically targeted adaptogen here; its strongest evidence concentrates in one population, women navigating perimenopause and menopause.

A 2025 randomized trial by Mahajan et al. found shatavari root extract effective and safe for perimenopausal symptoms including hot flashes, night sweats, anxiety, fatigue, and insomnia. A 2025 three-arm trial by Ademola et al. in Frontiers in Reproductive Health compared shatavari alone, shatavari with ashwagandha, and placebo, finding improvements on the Menopause Rating Scale and Perceived Stress Scale in both active arms.

Dose & Who It’s For: Trial doses have generally used around 300mg of standardized root extract over 8 to 12 weeks. Most relevant for perimenopausal and menopausal women managing vasomotor or mood symptoms; avoid without clinical guidance if you have a history of estrogen-sensitive conditions.

So What Should You Take

Nearly every adaptogen trial suffers from small samples, short durations, and inconsistent standardization. The mechanisms are plausible and the safety profiles are generally good, but effect sizes in healthy populations are reliably modest. These are tools for optimization and resilience, not therapeutic interventions.

The right one depends on what you’re trying to support: rhodiola for fatigue and chronic occupational load, lion’s mane for neuroplasticity and long-term cognitive health, ginseng for memory and attention, reishi for sleep-primary concerns, holy basil for stress that shows up physiologically, and shatavari for perimenopausal vasomotor and mood symptoms.